CERENOVUS THINKCERENOVUS Revenue and Competitors
Estimated Revenue & Valuation
- CERENOVUS THINKCERENOVUS's estimated annual revenue is currently $95.6M per year.
- CERENOVUS THINKCERENOVUS's estimated revenue per employee is $251,000
Employee Data
- CERENOVUS THINKCERENOVUS has 381 Employees.
- CERENOVUS THINKCERENOVUS grew their employee count by 9% last year.
CERENOVUS THINKCERENOVUS's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Project Manager | Reveal Email/Phone |
CERENOVUS THINKCERENOVUS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is CERENOVUS THINKCERENOVUS?
CERENOVUS, part of Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke. For more information, visit www.cerenovus.com.
keywords:N/A
N/A
Total Funding
381
Number of Employees
$95.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Irvine
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $100M | 381 | 5% | N/A |
#2 | $130.3M | 386 | 7% | N/A |
#3 | $300M | 392 | -6% | $210.6M |
#4 | $98.9M | 394 | N/A | N/A |
#5 | $50.8M | 406 | 10% | N/A |